Up to date with polypatent®: Worthwhile and informative
Here is where you can learn more about new developments and legal requirements relative to intellectual property rights, especially as they relate to patents, trademarks, utility models and designs. Our patent attorneys keep you informed with papers and articles and post links to formal regulations and detailed websites for additional background.
05.01.2012 . Patentability of embryos and human stem cells
The European Supreme Court (EuGH) considerably restricts the patentability of embryos and human stem cells
18.12.2011 . Change of procedural language for applications filed with the EPO
A change of the procedural language of an international application is not possible when entering the national phase before the EPO, if said PCT application was filed in one of the official languages of the EPO
07.12.2011 . Diclaimer II EPO
In the decision G02/10 the Enlarged Board of Appeal of the EPO had to consider the question whether an embodiment enclosed in the description of a patent application can be excluded from the scope of the claim via a disclaimer.
06.04.2011 . Patentability of enantiomers
Patentability of isolated enantiomers was clarified in the decision “Escalitopram” of the German Federal Supreme court (BGH) on September, 9th, 2009.
20.09.2010 . Second medical use claim formulation
A second medical use claim for new patent applications should not be further formulated in the “swiss type” form.